First New York Securities’s TherapeuticsMD TXMD Stock Holding History

First New York Securities’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$46.2K	Sell	160 -40	-20%	-$12.4K	0.09%	43
2016 Q3	$68.1K	Sell	200 -20	-9%	-$7.3K	0.05%	114
2016 Q2	$93.5K	Buy	220 +60	+38%	+$24.7K	0.06%	80
2016 Q1	$51.2K	Buy	+160	New	+$54.6K	0.04%	117

Other funds holding TXMD

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First New York Securities's TXMD Position: Q4 2016 in Review

First New York Securities reduced its TherapeuticsMD (TXMD) stake by 20% in Q4 2016, selling an estimated $12.4K and leaving 160 shares worth $46.2K. The position accounts for 0.09% of the portfolio, ranked #43.

First New York Securities first reported a position in TXMD in Q1 2016 and has held it in 4 quarters since. The position peaked at $93.5K in Q2 2016. 146 funds tracked by Wall St. Rank hold TXMD as of Q4 2016.

First New York Securities held 160 shares of TherapeuticsMD worth $46.2K as of Q4 2016.
First New York Securities sold 40 TherapeuticsMD shares in Q4 2016, an estimated $12.4K.
TherapeuticsMD made up 0.09% of First New York Securities's portfolio in Q4 2016, its #43 holding.
First New York Securities first reported a position in TherapeuticsMD in Q1 2016 and has held it in 4 quarters since.
First New York Securities's TherapeuticsMD position peaked at $93.5K in Q2 2016.
146 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.